Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer Philip J. SaylorNancy L. KeatingMatthew R. Smith Editorial 18 November 2012 Pages: 255 - 261
The Role of Dopamine Agonists in the Treatment of Depression in Patients with Parkinson’s Disease Albert F. G. Leentjens Review Article 18 November 2012 Pages: 273 - 286
Non-Hormonal Treatment Strategies for Vasomotor Symptoms Elise HallBenicio N. FreyClaudio N. Soares Review Article 18 November 2012 Pages: 287 - 304
Current Options and New Developments in the Treatment of Haemophilia Trisha WongMichael Recht Review Article 18 November 2012 Pages: 305 - 320
Current and Emerging Pharmacological Treatments for Gastrointestinal Stromal Tumour Kristen N. GanjooShreyaskumar Patel Review Article 18 November 2012 Pages: 321 - 330
Treatment of Viral Conjunctivitis with Antiviral Drugs Chrysanthi L. SkevakiIoanna E. GalaniAthanassios Tsakris Review Article 18 November 2012 Pages: 331 - 347
Sitagliptin/Metformin Fixed-Dose Combination Claudine M. Chwieduk Adis Drug Profile 18 November 2012 Pages: 349 - 361
Erratum to Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation S. T. DugganL. J. Scott Erratum 18 November 2012 Pages: 381 - 381